Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Avalo Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −26 vs. Q2 2022
- Shares held
- 5.55M
- −231.6K (−4.0%) vs. Q2 2022Converted for a 1-for-12 split
- Total value
- $18.4M
- −$16.3M (−46.9%) vs. Q2 2022
- New holders
- 3
- 6 more added
- Sold out
- 29
- 11 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $1.31B |
| Q1 2026 | 97 | $469.6M |
| Q4 2025 | 84 | $361.1M |
| Q3 2025 | 66 | $194.7M |
| Q2 2025 | 36 | $39.1M |
| Q1 2025 | 34 | $66.1M |
| Q4 2024 | 33 | $56.0M |
| Q3 2024 | 29 | $63.2M |
| Q2 2024 | 21 | $9.62M |
| Q1 2024 | 18 | $1.90M |
| Q4 2023 | 12 | $209.4K |
| Q3 2023 | 28 | $158.9K |
| Q2 2023 | 26 | $862.7K |
| Q1 2023 | 32 | $16.0M |
| Q4 2022 | 28 | $28.0M |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 54 | $34.7M |
| Q1 2022 | 71 | $56.2M |
| Q4 2021 | 75 | $136.0M |
| Q3 2021 | 77 | $175.5M |
| Q2 2021 | 71 | $218.1M |
| Q1 2021 | 70 | $180.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Avalo Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 3,964,666 | $13.2M | 0.33% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Nantahala Capital Management, LLC | 547,814 | $1.82M | 0.18% | −11,380−2.0% | ReducedConverted for a 1-for-12 split |
| Point72 Asset Management, L.P. | 500,737 | $1.66M | 0.01% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Vanguard Group Inc | 221,982 | $736.0K | 0.00% | −33,897−13.2% | ReducedConverted for a 1-for-12 split |
| BlackRock Inc. | 103,414 | $343.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Geode Capital Management, LLC | 51,420 | $170.0K | 0.00% | −19,112−27.1% | ReducedConverted for a 1-for-12 split |
| Millennium Management LLC | 51,012 | $169.0K | 0.00% | −33,245−39.5% | ReducedConverted for a 1-for-12 split |
| Goldman Sachs Group Inc | 35,644 | $118.0K | 0.00% | −18,494−34.2% | ReducedConverted for a 1-for-12 split |
| State Street Corp | 25,643 | $85.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Assenagon Asset Management S.A. | 15,646 | $52.0K | 0.00% | +15,646 | New |
| Morgan Stanley | 11,599 | $38.0K | 0.00% | +8,228+244.1% | AddedConverted for a 1-for-12 split |
| Northern Trust Corp | 10,855 | $36.0K | 0.00% | +1,150+11.8% | AddedConverted for a 1-for-12 split |
| UBS Group AG | 6,760 | $22.0K | 0.00% | +6,050+851.4% | AddedConverted for a 1-for-12 split |
| Meeder Asset Management Inc | 1,506 | $5.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| BNP Paribas Arbitrage, SA | 717 | $2.38K | 0.00% | +717 | New |
| TCI Wealth Advisors, Inc. | 251 | $1.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Group One Trading, L.P. | 183 | $1.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| FMR LLC | 35 | $0 | 0.00% | −67−65.6% | ReducedConverted for a 1-for-12 split |
| Bank of America Corp | 4 | $0 | 0.00% | −0−7.7% | ReducedConverted for a 1-for-12 split |
| Wells Fargo & Company | 131 | $0 | 0.00% | −12−8.4% | ReducedConverted for a 1-for-12 split |
| The PNC Financial Services Group, Inc. | 6 | $0 | 0.00% | +2+33.3% | AddedConverted for a 1-for-12 split |
| New York State Common Retirement Fund | 1 | $0 | 0.00% | −42−97.7% | ReducedConverted for a 1-for-12 split |
| Kistler-Tiffany Companies, LLC | 2 | $0 | 0.00% | +0+4.3% | AddedConverted for a 1-for-12 split |
| Advisor Group Holdings, Inc. | 1 | $0 | 0.00% | −41−97.6% | ReducedConverted for a 1-for-12 split |
| Parallel Advisors, LLC | 1 | $0 | 0.00% | +1+100.0% | AddedConverted for a 1-for-12 split |
| Newbridge Financial Services Group, Inc. | 10 | $0 | 0.00% | −1−7.0% | ReducedConverted for a 1-for-12 split |
| Tower Research Capital LLC (TRC) | 99 | $0 | 0.00% | +99 | New |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −37,500−100.0% | Sold outConverted for a 1-for-12 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −28,336−100.0% | Sold outConverted for a 1-for-12 split |
| Ergoteles LLC | 0 | $0 | 0.00% | −23,714−100.0% | Sold outConverted for a 1-for-12 split |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −17,307−100.0% | Sold outConverted for a 1-for-12 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −7,414−100.0% | Sold outConverted for a 1-for-12 split |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −4,746−100.0% | Sold outConverted for a 1-for-12 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −4,026−100.0% | Sold outConverted for a 1-for-12 split |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −3,692−100.0% | Sold outConverted for a 1-for-12 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −2,734−100.0% | Sold outConverted for a 1-for-12 split |
| Stifel Financial Corp | 0 | $0 | 0.00% | −2,500−100.0% | Sold outConverted for a 1-for-12 split |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −2,173−100.0% | Sold outConverted for a 1-for-12 split |
| Orion Portfolio Solutions, LLC | 0 | $0 | 0.00% | −2,123−100.0% | Sold outConverted for a 1-for-12 split |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −1,667−100.0% | Sold outConverted for a 1-for-12 split |
| Creative Planning | 0 | $0 | 0.00% | −1,697−100.0% | Sold outConverted for a 1-for-12 split |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −1,281−100.0% | Sold outConverted for a 1-for-12 split |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −1,333−100.0% | Sold outConverted for a 1-for-12 split |
| Avantax Planning Partners, Inc. | 0 | $0 | 0.00% | −1,055−100.0% | Sold outConverted for a 1-for-12 split |
| Moody Lynn & Lieberson, LLC | 0 | $0 | 0.00% | −833−100.0% | Sold outConverted for a 1-for-12 split |
| Mayflower Financial Advisors, LLC | 0 | $0 | 0.00% | −833−100.0% | Sold outConverted for a 1-for-12 split |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −476−100.0% | Sold outConverted for a 1-for-12 split |
| Legal & General Group Plc | 0 | $0 | 0.00% | −352−100.0% | Sold outConverted for a 1-for-12 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −330−100.0% | Sold outConverted for a 1-for-12 split |
| Washington Trust Co | 0 | $0 | 0.00% | −250−100.0% | Sold outConverted for a 1-for-12 split |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −154−100.0% | Sold outConverted for a 1-for-12 split |
| Citigroup Inc | 0 | $0 | 0.00% | −193−100.0% | Sold outConverted for a 1-for-12 split |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −148−100.0% | Sold outConverted for a 1-for-12 split |
| Barclays PLC | 0 | $0 | 0.00% | −16−100.0% | Sold outConverted for a 1-for-12 split |
| Credit Suisse AG | 0 | $0 | 0.00% | −3−100.0% | Sold outConverted for a 1-for-12 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold outConverted for a 1-for-12 split |
| Minot Wealth Management LLC | – | – | – | – | Not filed |